Opioid maker Mallinckrodt agrees bankruptcy plan

Pharmaceutical company Mallinckrodt has filed a bankruptcy plan that has the support of the majority of opioid litigation claimants. The bankruptcy plan relates to Mallinckrodt’s role in the US opioid epidemic. Mallinckrodt is due to face two trials in the US where it is claimed that the company illegally marketed opioids and failed to provide appropriate oversight of large shipments of opioid painkiller drugs.